These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33582664)

  • 41. Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMI.
    Rodriguez-Palomares JF; Gavara J; Ferreira-González I; Valente F; Rios C; Rodríguez-García J; Bonanad C; García Del Blanco B; Miñana G; Mutuberria M; Nuñez J; Barrabés J; Evangelista A; Bodí V; García-Dorado D
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2445-2456. PubMed ID: 31202752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF
    Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
    Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Initial Culprit Vessel Flow on Infarct Size, Microvascular Obstruction, and Myocardial Salvage in Acute Reperfused ST-Elevation Myocardial Infarction.
    Joost A; Stiermaier T; Eitel C; Fuernau G; de Waha S; Desch S; Thiele H; Eitel I
    Am J Cardiol; 2016 Nov; 118(9):1316-1322. PubMed ID: 27600465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
    Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
    Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction.
    Eitel I; Stiermaier T; Lange T; Rommel KP; Koschalka A; Kowallick JT; Lotz J; Kutty S; Gutberlet M; Hasenfuß G; Thiele H; Schuster A
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1433-1444. PubMed ID: 29454776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients.
    Bulluck H; Nicholas J; Crimi G; White SK; Ludman AJ; Pica S; Raineri C; Cabrera-Fuentes HA; Yellon D; Rodriguez-Palomares J; Garcia-Dorado D; Hausenloy DJ
    Int J Cardiol; 2017 Mar; 230():149-154. PubMed ID: 28038815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI).
    Hosseini SH; Talasaz AH; Alidoosti M; Tajdini M; Van Tassell BW; Etesamifard N; Kakavand H; Jalali A; Aghakouchakzadeh M; Gheymati A; Sadeghian M; Jenab Y
    J Cardiovasc Pharmacol; 2022 Oct; 80(4):592-599. PubMed ID: 35881907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; de la Torre-Hernandez JM; Gonzalez-Gonzalez J; Garcia-Camarero T; Consuegra-Sanchez L; Garcia-Saiz MD; Aldea-Perona A; Virgos-Aller T; Azpeitia A; Reiter RJ;
    J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27736028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.
    Sager HB; Husser O; Steffens S; Laugwitz KL; Schunkert H; Kastrati A; Ndrepepa G; Kessler T
    J Transl Med; 2019 May; 17(1):180. PubMed ID: 31142323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study.
    Steg P; Lopez-de-Sà E; Schiele F; Hamon M; Meinertz T; Goicolea J; Werdan K; Lopez-Sendon JL;
    Eur Heart J Acute Cardiovasc Care; 2013 Sep; 2(3):270-9. PubMed ID: 24222839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
    Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
    Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
    Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.
    Nicolau JC; Furtado RHM; Silva SA; Rochitte CE; Rassi A; Moraes JBMC; Quintella E; Costantini CR; Korman APM; Mattos MA; Castello HJ; Caixeta A; Dohmann HFR; de Carvalho ACC;
    Clin Cardiol; 2018 Mar; 41(3):392-399. PubMed ID: 29569254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.
    Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G;
    Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.